Explore the revolutionary Aptamer-RIBOTAC strategy for targeted microRNA degradation in cancer therapy - a breakthrough in precision oncology.
How electrochemical aptamer sensors are revolutionizing early detection of esophageal cancer through ultra-sensitive CEA biomarker detection